These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 29651784)
1. Are the effects of cognitive behavior therapy for severe fatigue in cancer survivors sustained up to 14 years after therapy? Van Gessel LD; Abrahams HJG; Prinsen H; Bleijenberg G; Heins M; Twisk J; Van Laarhoven HWM; Verhagen SCAHHVM; Gielissen MFM; Knoop H J Cancer Surviv; 2018 Aug; 12(4):519-527. PubMed ID: 29651784 [TBL] [Abstract][Full Text] [Related]
2. Graded activity is an important component in cognitive behavioral therapy to reduce severe fatigue: results of a pragmatic crossover trial in cancer survivors. Abrahams HJG; Gielissen MFM; Braamse AMJ; Bleijenberg G; Buffart LM; Knoop H Acta Oncol; 2019 Dec; 58(12):1692-1698. PubMed ID: 31524020 [No Abstract] [Full Text] [Related]
3. Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue. Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM; Webber K; Barry BK; Lloyd AR J Pain Symptom Manage; 2017 Jul; 54(1):74-84. PubMed ID: 28502786 [TBL] [Abstract][Full Text] [Related]
4. Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT. Voet N; Bleijenberg G; Hendriks J; de Groot I; Padberg G; van Engelen B; Geurts A Neurology; 2014 Nov; 83(21):1914-22. PubMed ID: 25339206 [TBL] [Abstract][Full Text] [Related]
5. The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance. Goedendorp MM; Knoop H; Gielissen MF; Verhagen CA; Bleijenberg G J Pain Symptom Manage; 2014 Jan; 47(1):35-44. PubMed ID: 23707383 [TBL] [Abstract][Full Text] [Related]
6. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Gielissen MF; Verhagen CA; Bleijenberg G Br J Cancer; 2007 Sep; 97(5):612-8. PubMed ID: 17653075 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up after cognitive behaviour therapy for chronic fatigue syndrome. Janse A; Nikolaus S; Wiborg JF; Heins M; van der Meer JWM; Bleijenberg G; Tummers M; Twisk J; Knoop H J Psychosom Res; 2017 Jun; 97():45-51. PubMed ID: 28606498 [TBL] [Abstract][Full Text] [Related]
8. Mindfulness-based cognitive therapy for people with chronic fatigue syndrome still experiencing excessive fatigue after cognitive behaviour therapy: a pilot randomized study. Rimes KA; Wingrove J Clin Psychol Psychother; 2013; 20(2):107-17. PubMed ID: 21983916 [TBL] [Abstract][Full Text] [Related]
9. Cognitive behavioral therapy positively affects fatigue in patients with multiple sclerosis: Results of a randomized controlled trial. van den Akker LE; Beckerman H; Collette EH; Twisk JW; Bleijenberg G; Dekker J; Knoop H; de Groot V; Mult Scler; 2017 Oct; 23(11):1542-1553. PubMed ID: 28528567 [TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of web-based cognitive behavioral therapy for severely fatigued breast cancer survivors (CHANGE-study): study protocol. Abrahams HJ; Gielissen MF; Goedendorp MM; Berends T; Peters ME; Poort H; Verhagen CA; Knoop H BMC Cancer; 2015 Oct; 15():765. PubMed ID: 26500019 [TBL] [Abstract][Full Text] [Related]
11. Study protocol of the TIRED study: a randomised controlled trial comparing either graded exercise therapy for severe fatigue or cognitive behaviour therapy with usual care in patients with incurable cancer. Poort H; Verhagen CA; Peters ME; Goedendorp MM; Donders AR; Hopman MT; Nijhuis-van der Sanden MW; Berends T; Bleijenberg G; Knoop H BMC Cancer; 2017 Jan; 17(1):81. PubMed ID: 28129746 [TBL] [Abstract][Full Text] [Related]
12. Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up. Schmidt ME; Wiskemann J; Schneeweiss A; Potthoff K; Ulrich CM; Steindorf K Int J Cancer; 2018 Mar; 142(6):1148-1157. PubMed ID: 29082588 [TBL] [Abstract][Full Text] [Related]
13. Potential mechanisms of the fatigue-reducing effect of cognitive-behavioral therapy in cancer survivors: Three randomized controlled trials. Müller F; Wijayanto F; Abrahams H; Gielissen M; Prinsen H; Braamse A; van Laarhoven HWM; Groot P; Heskes T; Knoop H Psychooncology; 2021 Sep; 30(9):1476-1484. PubMed ID: 33899978 [TBL] [Abstract][Full Text] [Related]
14. Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design. Kröz M; Reif M; Glinz A; Berger B; Nikolaou A; Zerm R; Brinkhaus B; Girke M; Büssing A; Gutenbrunner C; BMC Cancer; 2017 Mar; 17(1):166. PubMed ID: 28253845 [TBL] [Abstract][Full Text] [Related]
17. Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: One-year follow-up of the Qure study. Raijmakers RPH; Keijmel SP; Breukers EMC; Bleijenberg G; van der Meer JWM; Bleeker-Rovers CP; Knoop H J Psychosom Res; 2019 Jan; 116():62-67. PubMed ID: 30654996 [TBL] [Abstract][Full Text] [Related]
18. Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome. Janse A; Bleijenberg G; Knoop H J Psychosom Res; 2019 Jun; 121():93-99. PubMed ID: 31006534 [TBL] [Abstract][Full Text] [Related]
19. Cognitive behavioral therapy or graded exercise therapy compared with usual care for severe fatigue in patients with advanced cancer during treatment: a randomized controlled trial. Poort H; Peters MEWJ; van der Graaf WTA; Nieuwkerk PT; van de Wouw AJ; Nijhuis-van der Sanden MWG; Bleijenberg G; Verhagen CAHHVM; Knoop H Ann Oncol; 2020 Jan; 31(1):115-122. PubMed ID: 31912784 [TBL] [Abstract][Full Text] [Related]
20. Tailored exercise interventions to reduce fatigue in cancer survivors: study protocol of a randomized controlled trial. Twomey R; Martin T; Temesi J; Culos-Reed SN; Millet GY BMC Cancer; 2018 Jul; 18(1):757. PubMed ID: 30041626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]